A61K 41/17
By ultraviolet [uv] or infrared [ir] light, x-rays or gamma rays
Official title: by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
A61K41/17 (By ultraviolet [uv] or infrared [ir] light, x-rays or gamma rays) appears on 221 US grants and 273 published applications in this corpus.
Search patents in A61K- Granted patents
- 221
- Published applications
- 273
- Assignees
- 173
- Inventors
- 587
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 2 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 3 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 8 | 0 |
| 1997 | 10 | 0 |
| 1998 | 11 | 0 |
| 1999 | 14 | 0 |
| 2000 | 8 | 0 |
| 2001 | 12 | 4 |
| 2002 | 8 | 14 |
| 2003 | 12 | 21 |
| 2004 | 4 | 11 |
| 2005 | 4 | 12 |
| 2006 | 7 | 7 |
| 2007 | 6 | 16 |
| 2008 | 1 | 11 |
| 2009 | 2 | 8 |
| 2010 | 4 | 18 |
| 2011 | 5 | 8 |
| 2012 | 8 | 6 |
| 2013 | 3 | 6 |
| 2014 | 7 | 3 |
| 2015 | 4 | 8 |
| 2016 | 7 | 5 |
| 2017 | 4 | 14 |
| 2018 | 4 | 11 |
| 2019 | 3 | 13 |
| 2020 | 5 | 6 |
| 2021 | 6 | 9 |
| 2022 | 2 | 11 |
| 2023 | 4 | 18 |
| 2024 | 6 | 20 |
| 2025 | 8 | 6 |
| 2026 | 10 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Substituted tetrazoles as ACSS2 inhibitors7 Jul 2026US 12,673,046 B2Merck Patent GmbH
- Bacterial membrane vesicles, and separation and preparation system and method therefor9 Jun 2026US 12,648,990 B2Sichuan University
- Application of bacteria in preparation of synergist for immune checkpoint inhibitor19 May 2026US 12,629,396 B2Sun Yat-Sen University Cancer Center
- Lenses for treating ocular diseases and preparation method thereof5 May 2026US 12,616,652 B2Guangdong ProCapZoom Biosciences Co., Ltd.
- Methods of preventing platelet alloimmunization and alloimmune platelet refractoriness and induction of tolerance in transfused recipients14 Apr 2026US 12,599,667 B2Bloodworks
- Ophthalmic formulation for topical use containing helenalin, 11a,13-dihydro helenalin and flavonoids from arnica montana extract and sodium hyaluronate, and use thereof by humans to treat dry eye syndrome16 Jul 2026US 2026/0199417 A1Centro De Retina Medica Y Quirurgica, S.C.
- Manufacturing of selenium disulfide compositions2 Jul 2026US 2026/0183332 A1Azura Ophthalmics Ltd.
- Cryoprecipitate compositions and methods of preparation thereof11 Jun 2026US 2026/0158062 A1Cerus Corporation
- Peptide particles and methods of formation5 Mar 2026US 2026/0060929 A1Elektrofi, Inc.
- Anaerobic Blood Storage and Pathogen Inactivation Method12 Feb 2026US 2026/0041772 A1Hemanext Inc.
Most cited
By later US patents
- Apparatus and method for killing unwanted cells134US 4,395,397 ASidney Farber Cancer Institute, Inc. · 1983
- Method of inactivation of viral and bacterial blood contaminants114US 5,418,130 ACryopharm Corporation · 1995
- Method and compositions for treatments of cancers104US 6,231,536 B12001
- Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen99US 5,459,030 ASteritech, Inc. · 1995
- Photodynamic inactivation of viruses in blood cell-containing compositions94US 5,120,649 ANew York Blood Center, Inc. · 1992